162 related articles for article (PubMed ID: 34382414)
1. Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer.
Yılmaz H; Yılmaz A; Demirağ G
Future Oncol; 2021 Oct; 17(29):3853-3864. PubMed ID: 34382414
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer.
Yılmaz A; Yılmaz H; Tekin SB; Bilici M
Biomark Med; 2020 Jun; 14(9):727-738. PubMed ID: 32648774
[No Abstract] [Full Text] [Related]
3. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
[TBL] [Abstract][Full Text] [Related]
4. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study.
Yılmaz A; Mirili C; Tekin SB; Bilici M
Ir J Med Sci; 2020 Feb; 189(1):91-102. PubMed ID: 31832860
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma.
Gu L; Ma X; Xie Y; Li H; Wang L; Chen L; Zhao W; Zhang Y; Zhang X
Clin Genitourin Cancer; 2017 Jun; 15(3):e369-e377. PubMed ID: 28038932
[TBL] [Abstract][Full Text] [Related]
6. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Hutterer GC; Stoeckigt C; Stojakovic T; Jesche J; Eberhard K; Pummer K; Zigeuner R; Pichler M
Urol Oncol; 2014 Oct; 32(7):1041-8. PubMed ID: 25027686
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of hemoglobin-to-red cell distribution width ratio in cancer: a systematic review and meta-analysis.
Chi G; Lee JJ; Montazerin SM; Marszalek J
Biomark Med; 2022 Apr; 16(6):473-482. PubMed ID: 35272482
[TBL] [Abstract][Full Text] [Related]
8. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
Bozkaya Y; Kurt B; Gürler F
Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.
Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ
BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476
[TBL] [Abstract][Full Text] [Related]
10. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma.
Chang Y; Fu Q; Xu L; Zhou L; Liu Z; Yang Y; Lin Z; Xu J
Tumour Biol; 2016 Apr; 37(4):4613-20. PubMed ID: 26508025
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma.
Yamamoto Y; Matsuyama H; Matsumoto H; Sakano S; Fuji N; Oba K; Yamamoto M; Kamiryo Y; Hiragino T; Nagao K; Takai K; Aoki A
Jpn J Clin Oncol; 2020 Feb; 50(2):214-220. PubMed ID: 31755525
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score matching analysis.
Jiang H; Jiang W; Tan L; Yu Q; Liu F; Huang Y; He J; Zhou S
J Int Med Res; 2021 Apr; 49(4):3000605211004229. PubMed ID: 33823630
[TBL] [Abstract][Full Text] [Related]
15. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
[TBL] [Abstract][Full Text] [Related]
16. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
Chen JL; Wu JN; Lv XD; Yang QC; Chen JR; Zhang DM
PLoS One; 2020; 15(8):e0237947. PubMed ID: 32833961
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of hematologic parameters in patients with metastatic renal cell carcinoma using tyrosine kinase inhibitors.
Gunduz S; Mutlu H; Uysal M; Coskun HS; Bozcuk H
Asian Pac J Cancer Prev; 2014; 15(8):3801-4. PubMed ID: 24870797
[TBL] [Abstract][Full Text] [Related]
18. [Influence of the Ratio of Peripheral Hemoglobin-to-Red Cell Distribution width on the Prognosis of Patients with Diffuse Large B-cell Lymphoma].
Dong XY; Tang GF; Chen W; Cao J; Cheng H; Li ZY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):765-770. PubMed ID: 35680803
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.
Konishi S; Hatakeyama S; Tanaka T; Ikehata Y; Tanaka T; Hamano I; Fujita N; Yoneyama T; Yamamoto H; Yoneyama T; Hashimoto Y; Yoshikawa K; Kawaguchi T; Masumori N; Kitamura H; Ohyama C
Int J Urol; 2019 Oct; 26(10):992-998. PubMed ID: 31342557
[TBL] [Abstract][Full Text] [Related]
20. The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer.
İlhan A; Gurler F; Yilmaz F; Eraslan E; Dogan M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2060-2067. PubMed ID: 36930504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
